|Taxonomy Citation ID||Reference|
|6787||Judicial Commission "Minutes of the Meeting, 14 September 1990, Osaka, Japan." Int. J. Syst. Bacteriol. (1991) 41:185-187. (Note: Yokonella and Yokonella regensburgei are recognized as senior heterotypic synonyms of Koserella and Koserella trabulsii, respectively.) [No PubMed record available.]|
|6785||Kosako, Y., Sakazaki, R., Huntley-Carter, G.P., and Farmer III, J.J. "Yokenella regensburgei and Koserella trabulsii are subjective synonyms." Int. J. Syst. Bacteriol. (1987) 37:127-129. [No PubMed record available.]||6781||
( 1985 )
Koserella trabulsii, a new genus and species of Enterobacteriaceae formerly known as Enteric Group 45.
PMID : 3968202 PMC : PMC271576
The name Koserella trabulsii is proposed for a group of Enterobacteriaceae formerly called Enteric Group 45. This group consists of 12 strains that were originally identified as atypical Hafnia alvei. K. trabulsii strains were negative for indole production, Voges-Proskauer, H2S production, urea hydrolysis, phenylalanine deaminase, and acid production from glycerol, lactose, sucrose, and D-sorbitol; they were positive for methyl red, citrate (Simmons), lysine and ornithine decarboxylases, arginine dihydrolase (negative in 1 to 2 days and positive in 3 to 7 days), and acid production from cellobiose and melibiose; and they were resistant to the Hafnia-specific bacteriophage of Guin?e and Valkenburg. They were tested for DNA relatedness by the hydroxyapatite method with 32PO4-labeled DNA from the designated type strain (CDC 3349-72, ATCC 35313). The 12 strains were 87 to 99% related in 60 degrees C reactions. Relatedness of K. trabulsii to 71 DNA hybridization reference strains of representative species of Enterobacteriaceae was 4 to 37%. It was 15 to 16% related to H. alvei. All strains were susceptible to nalidixic acid, sulfadiazine, gentamicin, kanamycin, and chloramphenicol, and 83% were susceptible to nalidixic acid, sulfadiazine, gentamicin, kanamycin, and chloramphenicol, and 83% were susceptible to tetracycline. Most of the strains were resistant or intermediate to penicillin, ampicillin, carbenicillin, colistin, and cephalothin. Five of the strains were isolated from wounds, three were from the respiratory tract, and one each was from a stool, knee fluid, water, and an unknown source. The clinical significance of this organism is not known; therefore, future studies should focus on its isolation and its relationship to human disease.
|6786||Kosako, Y., and Sakazaki, R. "Priority of Yokenella regensburgei Kosako, Sakazaki, and Yoshizaki 1985 over Koserella trabulsii Hickman-Brenner, Huntley-Carter, Brenner, and Farmer 1985." Int. J. Syst. Bacteriol. (1991) 41:171. [No PubMed record available.]|
|6788||VALIDATION LIST No. 17. Int. J. Syst. Bacteriol. (1985) 35:223-225.|
|6789||VALIDATION LIST No. 17. Int. J. Syst. Bacteriol. (1985) 35:223-225.||6784||
( 1984 )
Yokenella regensburgei gen. nov., sp. nov.: a new genus and species in the family Enterobacteriaceae.
PMID : 6503024
The name Yokenella gen. nov. is proposed for a group of organisms in the family Enterobacteriaceae isolated from clinical sources and insects. Yokenella is a gram-negative, oxidase-negative, fermentative, motile rod possessing the characteristics of the family Enterobacteriaceae and the guanine plus cytosine contents of the DNA range from 58.0 to 59.3 mol%. Biochemical characteristics of this group and DNA hybridization studies indicate that the 11 strains studied here comprise a separate species which should be best placed in a new genus. This single DNA hybridization group is named Yokenella regensburgei sp. nov. The type strain of Y. regensburgei is NIH 725-83 (JCM 2403).